The DOI matches its Crossref record; 212 of the 213 references it cites were found in a registry or an index.
Targeting IL-6 trans-signalling: past, present and future prospects
Open accessAbstract
Interleukin-6 (IL-6) is a key immunomodulatory cytokine that affects the pathogenesis of diverse diseases, including autoimmune diseases, chronic inflammatory conditions and cancer. Classical IL-6 signalling involves the binding of IL-6 to the membrane-bound IL-6 receptor α-subunit (hereafter termed ‘mIL-6R’) and glycoprotein 130 (gp130) signal-transducing subunit. By contrast, in IL-6 trans-signalling, complexes of IL-6 and the soluble form of IL-6 receptor (sIL-6R) signal via membrane-bound gp130. A third mode of IL-6 signalling — known as cluster signalling — involves preformed complexes of membrane-bound IL-6–mIL-6R on one cell activating gp130 subunits on target cells. Antibodies and small molecules have been developed that block all three forms of IL-6 signalling, but in the past decade, IL-6 trans-signalling has emerged as the predominant pathway by which IL-6 promotes disease pathogenesis. The first selective inhibitor of IL-6 trans-signalling, sgp130, has shown therapeutic potential in various preclinical models of disease and olamkicept, a sgp130Fc variant, had promising results in phase II clinical studies for inflammatory bowel disease. Technological developments have already led to next-generation sgp130 variants with increased affinity and selectivity towards IL-6 trans-signalling, along with indirect strategies to block IL-6 trans-signalling. Here, we summarize our current understanding of the biological outcomes of IL-6-mediated signalling and the potential for targeting this pathway in the clinic. This Review details the discovery of the interleukin-6 (IL-6) trans-signalling pathway and the subsequent development of biologics that specifically inhibit this pathway. Emerging evidence suggests that specifically targeting IL-6 trans-signalling can reduce pathological disease-promoting activities of IL-6 without blocking the protective actions of IL-6 in infection and tissue repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In MM cells, the JAK/STAT3 pathway is triggered by cytokines from the gp130 receptor family, such as IL-6, leukemia inhibitory factor (LIF), and oncostatin-M (OSM).”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [108]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the binding of IL-6 to its receptor (IL-6R) leads to the activation of JAK1, which phosphorylates STAT3, thereby activating the JAK/STAT pathway [108].”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [108]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Soluble gp130Fc, named olamkicept or TJ301, is consists of two soluble human gp130 proteins fused with the Fc of human IgG, and selectively targets the IL-6-sIL-6R complex [79].”
From The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases (2024) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As IL-6 classic signaling plays crucial roles in the initiation of inflammation and the host defense against pathogen infection, global blockade of IL-6 signaling may reduce the induction of hepatic acute-phase proteins upon infection, such as Listeria monocytogenes [79].”
From The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases (2024) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationHirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · cited 1×
“Dysregulated IL-6 signalling is a hallmark of infections, including SARS-CoV-2, that are characterized by hyperinflammation 137–145 , with high IL-6 levels in patients with COVID-19 being implicated in the depletion of CD4 + T cells, CD8 + T cells and natural killer cells 146 .”
Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00676-0 · Cited by 1,983
Interleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 2×
“Studies in IL-6-deficient mice showed that IL-6 contributes to the pathogenesis of many inflammatory diseases, including bacterial and viral infections 66 , arthritis 67,68 , experimental colitis 69 and multiple sclerosis 70 .”
Gauldie, J., Richards, C. D., Harnish, D. C., Lansdorp, P. M., & Baumann, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Research works printed but not linked: 1
- Kang, S., Narazaki, M., Metwally, H. & Kishimoto, T. Historical overview of the interleukin-6 family cytokine. J. Exp. Med. 2020, 5 (2020).
Cited by
Sorted by citations
Items 301–400 of 555
Matos, P., & Jordan, P. (2025) · Cancers · doi:10.3390/cancers17020219 · Cited by 3
Investigation of Novel Therapeutic Targets for Rheumatoid Arthritis Through Human Plasma Proteome
Wang, H., Huang, C., Huang, K., Wu, T., & Liu, H. (2025) · Biomedicines · doi:10.3390/biomedicines13081841 · Cited by 3
Li, C., Wen, R., Xiong, Y., Tan, Q.-W., Zhai, X., Xiong, Y., & Dai, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115469 · Cited by 3
Qiao, Y., Han, Y., Zhao, L., Gao, W., Hu, H., Su, C., Zheng, A., Sun, J., Tian, M., Wu, Y., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00320-4 · Cited by 3
Blood Cytokine Levels in Patients with Alcohol Dependence during Early Withdrawal Treatment
Hsu, S.-H., Kao, C.-F., Chang, H., Meng, S.-C., Shi, J., & Huang, M. (2023) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_31_23 · Cited by 4
Baumgärtner, L. A. F., Ettich, J., Balles, H., Lapp, D. J., Moßner, S., Bassenge, C., Ouzin, M., Hanenberg, H., Scheller, J., & Floss, D. M. (2024) · Biological Chemistry · doi:10.1515/hsz-2023-0344 · Cited by 3
Self-citationWei, W., Li, X., & Li, Z. (2024) · Biopolymers · doi:10.1002/bip.23605 · Cited by 3
Sarrafi, S., Vahedi, L., Pourzainali, S., Ranjbar, M., Farshbaf‐Khalili, A., & Babaie, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36247 · Cited by 3
Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis
Blommers, M., Selegean, S., Wood, R. K., Bustamante, M. S., Shyamsundar, S., Wiley, E. A., Comeau, E. M., Shawwa, A., Rose‐John, S., Fajgenbaum, D. C., et al. (2024) · European Journal Of Haematology · doi:10.1111/ejh.14295 · Cited by 3
Self-citationGarbers, C., & Werfel, T. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.08.028 · Cited by 3
Self-citationInvestigating plasticity within the interleukin-6 family with AlphaFold-Multimer
Düsterhöft, S., Greve, J. N., & Garbers, C. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.02.030 · Cited by 3
Self-citationBridging the inflammation gap by IL-6 inhibition
Shapiro, M. D. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00702-5 · Cited by 3
Li, X., Zhao, Z., Ye, H., Li, D., Huang, X., Lee, J.-H., & Liu, R. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02189-w · Cited by 2
Association of the IL‐6R rs2228145 polymorphism with diabetic nephropathy: A case‐control study
Izakovicova, P., Slezáková, S., Deissová, T., Poskerová, H., Linhartová, P. B., Dušek, L., Kaňková, K., & Hollá, L. I. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70073 · Cited by 2
Li, H., & Thirupathi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1639427 · Cited by 2
Advances in biomimetic nano delivery systems for pulmonary hypertension therapy
Zhao, P., Wang, M., Liu, Z., Zhang, M., Cai, Z., Zhang, B., Shi, Z., Liu, M., & Cheng, Y. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.08.034 · Cited by 2
Zhang, J., Wang, Y., Li, X., Gao, H., Wang, C., Cai, T., Wang, Y., Wang, H., Li, Z., & Cheng, Y. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c04062 · Cited by 2
Liao, C., Su, H., Li, F., Wang, C., Yang, S., Qin, Z., & Li, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690388 · Cited by 2
Wu, Z., Liu, W., Wang, M., Gebre, B. A., Abate, S., Huang, W., Sui, Z., & Corke, H. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70681 · Cited by 2
Gao, S., Wang, X., Bao, R., Yang, Q., Cai, Q., Zhang, Y., Peng, Z., Huang, L., & Wang, X. (2025) · Animals · doi:10.3390/ani15243585 · Cited by 2
Interleukin-6 in Natural and Pathophysiological Kidney Aging
Mutig, K., Singh, P. B., & Lebedeva, S. V. (2026) · Cells · doi:10.3390/cells15030225 · Cited by 2
Chakrapani, V., Kale, K., Crawford, M. P., & Karandikar, N. J. (2026) · European Journal of Immunology · doi:10.1002/eji.70150 · Cited by 2
Bouka, M., Nimptsch, K., Pham, T. T., Bouras, E., Kanellopoulou, A., Phipps, A. I., Guelpen, B. R. V., Brenner, H., Li, L., Marchand, L. L., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04736-9 · Cited by 2
Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets
Cami, E., Verghote, E., Pecetto, E., González, A., Bråkenhielm, E., Jones, E. A. V., & van Empel, V. P. M. (2026) · Current Heart Failure Reports · doi:10.1007/s11897-026-00745-0 · Cited by 2
Sex-biased plasma inflammatory protein profile in obesity
Halland, H., Vitorino, R. M. P., Gerdts, E., Midtbø, H. B., Meyer, K., & Kararigas, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-44223-y · Cited by 2
Wu, J. G., Taylor, J., Kunkel, D., Maze, M., Pearce, R. A., Sanders, R. D., & Lennertz, R. C. (2026) · BJA Open · doi:10.1016/j.bjao.2026.100546 · Cited by 2
Cordero, A., Frazier, M. R., Jost, G. M., Hostinar, C. E., & Swartz, J. R. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106827 · Cited by 2
Ayeldeen, G. M., Shaker, O. G., Ahmed, M. I., & Abd‐Elmawla, M. A. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110877 · Cited by 2
Yoon, T., Ahn, S. S., Ko, E., Song, J. J., Park, Y., & Lee, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227059 · Cited by 2
The Role Of Biologic Therapies In Improving Joint Health In Autoimmune Arthritis
Alanazi, S. S., Almalki, I. H., Alandijani, A. A., Thubab, H. M., Alkheledan, H. S., Alsufyani, S. A., Alharthi, S. A., nass, A. M. A., AlSultan, I. A., Alshahrani, A. M., et al. (2023) · Journal of Survey in Fisheries Sciences · doi:10.53555/sfs.v10i5.2298 · Cited by 2
Tie, S., Tong, T., Zhan, G., Li, X., Ouyang, D., & Cao, J. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002074 · Cited by 2
Lin, J., Liu, X., Chen, X., Yang, M., Han, L., Xu, R., & Zhang, D. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116219 · Cited by 2
Li, X., Zhang, Y., & Zhang, G. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x294637240517050849 · Cited by 2
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Bento, R., Scheller, J., & Parekkadan, B. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01230-6 · Cited by 2
Self-citationRadicetti-Silva, J., Oliveira, M. V., Baldavira, C. M., Braga, C. L., Santos, R. T., Felix, N. S., da Silva, A. L., Capelozzi, V. L., Cruz, F. F., Rocco, P. R. M., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.07.009 · Cited by 2
Direct Effects of Inflammatory Cytokines on Mouse Uterine Contraction
Bao, J., Zhao, C., Wang, X., Liu, S., Wang, L., Zou, Y., & Liu, H. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13938 · Cited by 2
Tjiptaningrum, A., Kurniati, I., Fadilah, F., Susantiningsih, T., Prawiningrum, A. F., Utari, W. D., & Erlina, L. (2024) · International Journal of Inflammation · doi:10.1155/ijin/5568294 · Cited by 2
Rafeeqi, T. A., Pandith, R. A., Humma, H., Shah, A., Zakir, M., Anjum, N., Ara, I., & Ahmed, N. Z. (2025) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2025.100999 · Cited by 2
Li, Y., & Singh, S. P. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128344776250222043907 · Cited by 2
Mao, L., Xie, Q., Cheng, Q., Tang, W., & Mao, L. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106749 · Cited by 2
Role of Interleukin-6 Mediated T Cell Activation in Experimental Acute Pancreatitis
Glaubitz, J., Zimdahl, A., Zeißig, S., Weiß, F. U., & Sendler, M. (2025) · Inflammation · doi:10.1007/s10753-025-02329-x · Cited by 2
Cancer-Associated Fibroblast-Driven Progression of HPV+ Head and Neck Cancer with Organoid Models
Xue, P. X., Xiao, R., Chen, L., Yang, G., Fan, C., Zhu, J., Zhao, J., Zhang, H., Sun, L., & Sun, S. Y. (2025) · Journal of Dental Research · doi:10.1177/00220345251342168 · Cited by 2
sIL-6R impact on aortic aneurysm: Genetic evidence from FinnGen and GWAS
Wang, M., Teng, T., Mo, D.-G., Zhang, N., Chen, R., Xu, J., Dong, Z., Zhang, N., & Yu, H. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133786 · Cited by 2
Serbest Zamanın Kendini Gerçekleştirme Açısından Ele Alınması
Aksoy, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub246.c1063 · Cited by 2
Spor Bilimleri Üzerine Araştırmalar-VI
ULUÇ, E. A., Şahin, A., Ünver, D., Beyazçiçek, E., Beyazçiçek, E., Aksoy, S., Yılmaz, T., Özcan, V., & Günay, M. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub246 · Cited by 1
Sporun Bireylerin Akıllı Telefon Kullanımına Etkisinin İncelenmesi
Yılmaz, T. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub246.c1065 · Cited by 1
Aziz, N., Shih, R., Alexopoulos, N., Jamieson, B. D., Mimiaga, M. J., Martı́nez-Maza, O., & Detels, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290702 · Cited by 1
Increased Soluble Interleukin 6 Receptors in Fabry Disease
Lenzini, L., Iori, E., Vettore, M., Gugelmo, G., Radu, C. M., Padoan, A., Carraro, G., Simioni, P., Calò, L. A., Avogaro, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010218 · Cited by 1
Brisse, M. E., & Ly, H. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29572 · Cited by 1
Salar, A., Đerfi, K. V., Pačić, A., Škrtić, A., Čaćev, T., & Kapitanović, S. (2024) · Cancers · doi:10.3390/cancers16162916 · Cited by 1
Effects of Interleukin-6 (IL-6) on In Vitro Cultured Equine Chorionic Girdle Cells
Mu, S., Shen, Y., Ren, H., Ulaangerel, T., Yi, M., Zhao, B., Hao, A., Liu, Q., Wen, X., Dugarjaviin, M., et al. (2025) · Animals · doi:10.3390/ani15030450 · Cited by 1
Wunderlich, F. T., Daniela Gerovska, D., Delić, D., & Araúzo-Bravo, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073173 · Cited by 1
Franke, B. U., Kummer, K. K., Rose‐John, S., Lichtenthaler, S. F., & Kress, M. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156925 · Cited by 1
Self-citationXu, Y., & Mao, J. (2025) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2025.101633 · Cited by 1
Li, S., Chen, Q., Du, X., Gao, R., Li, L., Li, B., Han, S., Zhang, L., Xiu, M., He, J., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146339 · Cited by 1
Treg-specific IL-6R signaling: a novel role in the regulation of the intestinal epithelium
Klatt, E. E., Hamdan, F. H., Pérez, I., Smith, H., Kossick, K. F., Fedyshyn, Y., Sagstetter, M. R., Chiang, D. S., Chini, L. C. S., Davidson, H. M., et al. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00131.2025 · Cited by 1
Adipocyte-specific deletion of gp130 prevents ketogenic diet–induced hepatic steatosis
Senkalfa, B., Gloor, M., Podlaszewski, R., Dewal, R. S., Horváth, C., Efthymiou, V., Ghosh, A., Wueest, S., Konrad, D., Wolfrum, C., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000782 · Cited by 1
Zhu, M., Cao, M., & Lin, L. (2025) · Immune Network · doi:10.4110/in.2025.25.e31 · Cited by 1
Ormerod, M. B. E. G., Sheikh, M. A., Ueland, T., Hjell, G., Rødevand, L. N., Sæther, L. S., Lunding, S. H., Johansen, I. T., Andreou, D., Ueland, T., et al. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10104 · Cited by 1
Cong, W., Yuan, X., Hao, Y., Jia, H., Jiang, W., Gao, Q., Lv, X., Yang, H., Zheng, Y., Zhang, H., et al. (2025) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2025.100254 · Cited by 1
Cutting-edge approaches to diagnosing and treating limb ischemia in peripheral arterial disease
Okoro, G., Owunnah, F. K., Applegate, C. C., Nelappana, M. B., Dobrucki, I. T., & Dobrucki, L. W. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ae16f1 · Cited by 1
Tang, Q., Zhang, Y., Wang, Y., Liu, L., Song, C., Tang, S., & Lin, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117527 · Cited by 1
Flow cytometry-based validation of soluble biomarker detection
Tang, Y., Wu, X., Zhang, H., Dong, L., Cao, R., Chen, J., Zhu, J., Hu, L., Zhou, Q., Zhou, J., et al. (2025) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2025.e00510 · Cited by 1
Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications
van Niekerk, G., Kumpanenko, Y., Degryse, J., Fevery, J., & Dallmeier, K. (2025) · Protein & Cell · doi:10.1093/procel/pwaf096 · Cited by 1
Nguyen, D. T., Mendoza, K., Hall, C., Tan, C., & Chauhan, A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115562 · Cited by 1
Georgiev, V. P., Anderka, I., Bucher, D., Preiss, L. C., Zhang, J. D., Umehara, K., & Parrott, N. J. (2025) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2025.101510 · Cited by 1
Olokizumab therapy and cardiovascular complications in rheumatoid arthritis
Владимировна, З. Е., Baranov, A. A., Egorova, A. N., Lemak, M. S., Kuzkina, S., & Nasonov, E. L. (2025) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2025-611-618 · Cited by 1
Li, X., Zhang, J., Feng, Y., Zhou, Q., & Zhang, C. (2026) · Respiratory Research · doi:10.1186/s12931-025-03458-5 · Cited by 1
Host Responses to SARS-CoV-2 with an Emphasis on Cytokines
Hayashi, H., Kubo, Y., & Tanaka, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020664 · Cited by 1
Multi-organ metabolic dysregulation and cecal microbiota alterations following black carbon exposure
Wei, S., Li, W., Ran, S., Zhang, J., Zhang, Z., Yang, Z., Tian, F., Chen, L., Pj, H., Yuan, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.01.027 · Cited by 1
Friend or foe: New cytokine players in beta cell failure in type 1 diabetes mellitus
Gurgul-Convey, E., & Naujok, O. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120113 · Cited by 1
Alsudaney, M., Abdulhaleem, M. N., Attia, A. M., Liu, J., Adetyan, H., Khattab, O., Hendifar, A., & Kuo, A. (2026) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2025.90 · Cited by 1
Khrulev, A. Е., Chernova, O. M., Grigoryeva, V. N., Шиянова, Н. А., Хрулева, Н. С., & Мухина, И. В. (2026) · Современные технологии в медицине · doi:10.17691/stm2026.18.1.05 · Cited by 1
Zhang, Y., Li, W., Liang, Y., Zang, L., Chen, X., Xiong, X., Zhang, S., Li, Y., Qu, X., Geng, J., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117868 · Cited by 1
Li, D., Li, Y., Wang, Z., Zheng, X., Wang, Y., Guo, J., Li, J., Liu, Y., & Li, Y. (2026) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.109684 · Cited by 1
Unraveling the Link Between COVID-19 and Memory Deficits: The Role of Brain Microglia Activation
Aktaruzzaman, M., Abid, M. A., Rakib, M. A., Islam, M. S., Dona, H. A., Tabassum, A., Hossain, N., Sezin, S. N., Metu, C. L. N., & Raihan, M. O. (2026) · Neuroglia · doi:10.3390/neuroglia7010010 · Cited by 1
Guan, J., Xiao, L., Hong, J., (29560), J. W., Cai, G., Richardson, D. R., Liao, Y., & Yu, W. (2026) · Targetome · doi:10.48130/targetome-0026-0010 · Cited by 1
Belančić, A., Sener, S., Fajkić, A., Potočnjak, I., Benić, M. S., Vučković, M., Şener, Y. Z., Pavlović, M. R., Markotić, A., Radić, J., et al. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70219 · Cited by 1
Wen, Z., Xu, S., Cao, Z., Jin, W., Deng, S., Zhou, Q., Xia, X., & Wang, X. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112535 · Cited by 1
Structural basis for ADAM17 activation by the iRhom1 pseudoprotease
Ungvary, J., Maciag, J. J., Alnajjar, H. F., Dávila, E. M., Slone, C. E., Thomas, J. E., RICH, M. F., Carazo, S. A., Ifergan, I., Perez‐Aguilar, J. M., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117309 · Cited by 1
The metalloproteinase ADAM17 promotes acute lung inflammatory responses during pancreatitis
Chan, S., Hon, K., Dawson, R. E., Weng, T., Solujic, J., Chey, Y. C. J., Zuiani, J. D., Perkins, G. B., Coates, P. T., Drogemuller, C., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70443 · Cited by 1
Self-citationUpregulation of ADAM10 reinforces CD8 + T cells toward exhaustion in the TME
Abdalla, A. M. E., Miao, Y., Taha, Y. A., Meng, N., & Ouyang, C. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2669732 · Cited by 1
Kalkman, H. O., & Smigielski, L. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70466 · Cited by 1
Mounisamy, P., Singh, H., Vairappan, B., Rajasekar, G., Chandrashekar, S., Jeyaraman, N., & Jeyaraman, M. (2026) · World Journal of Orthopedics · doi:10.5312/wjo.v17.i5.116068 · Cited by 1
The anti-interleukin-6 antibody ALD518-P18 mitigates murine kidney ischemia–reperfusion injury
Bongoni, A. K., Biondo, M., McRae, J. L., Salvaris, E. J., Fisicaro, N., Muntz, F., Rowe, T., Morelli, A. B., & Cowan, P. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-54952-9 · Cited by 1
Orlandi, G., Overi, D., Tinco, R. D., Pisciotta, A., Bertani, G., Biasi, S. D., Leone, S., Cardinale, V., Franchitto, M., Miglietta, S., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101903 · Cited by 1
Rocha, G. D., Silva, A. T. P., Armstrong, A. D. C., de Souza, C. D. F., & do Carmo, R. F. (2026) · Human Immunology · doi:10.1016/j.humimm.2026.111773 · Cited by 1
Canal, C., Aguilar, K., Comes, G., Sanz, E., Giralt, M., Sanchís, P., & Hidalgo, J. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02101-9 · Cited by 1
Identifying Negative Biomarkers of CD4 Cytotoxic T Lymphocytes via Granzyme B Exclusion Analysis
Wang, B., Bahabayi, A., Huang, D. J. Y., Xiong, Z., Zhang, Z., Gao, Y. N., Han, W., Liu, C., & Wang, P. (2026) · European Journal of Immunology · doi:10.1002/eji.70213 · Cited by 1
Dehkhoda, F., Chhabra, Y., Whelan, F., Nowell, C. J., Morris, M. J., Furness, S. G. B., & Brooks, A. J. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag118 · Cited by 1
Zhu, Y., He, Q., Chen, Y., Lu, T., & Lü, S. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104728 · Cited by 1
Anti-inflammatory Bioactive Compounds for Cancer Therapy
Chaudhary, P., Babita, Mavi, A. K., & Adhana, S. (2026) · Food bioactive ingredients · doi:10.1007/978-3-032-23814-6_10 · Cited by 1
Zeng, R., Wang, M., Wang, K., Xing, Z., Hong, Y., Li, T., Zong, G., Yang, C., Zhang, D. H., Chen, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.76416 · Cited by 1
The role of CSF IL-6 levels in diagnosis and outcome prediction of autoimmune encephalitis
Shimizu, M., Hoshi, T., Sumikura, H., Higashida, K., Fukasaka, I., Shimada, Y., Sato, T., Ito, M., Tomoda, T., Sakaguchi, M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865851 · Cited by 1
Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease
Tuttle, K. R., Cherney, D. Z. I., Pecoits-Filho, R., Pirro, M., Yau, K., & Sahay, M. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106712 · Cited by 1
Bustos, M., & Rodríguez-Hernández, M. Á. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120198 · Cited by 1
The local–systemic axis of the skeletal muscle secretome
Ng, S. Y., & Handschin, C. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.07.001 · Cited by 1
Hanada, R., Bruzelius, K., Falkenberg, M., Kyhl, L., Møgelmose, S., Ravi, A., Pinton, P., & Yoneshima, N. (2026) · Clinical and Translational Science · doi:10.1111/cts.70673 · Cited by 1
Cytokine-mediated immune-to-brain signaling in neural circuit disorders
Lee, Y., Ko, J., & Um, J. W. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01796-y · Cited by 1
Interleukin-6 trans-signalling as a selectively targetable driver of neurodegeneration
Risby-Jones, G., Lee, J. D., & Fung, J. N. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.07.002 · Cited by 1
Metadata
- Authors
- Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J.
- Affiliations
- Hudson Institute of Medical Research (AU)
- Otto-von-Guericke-Universität Magdeburg (DE)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Scheller, Jürgen
- Venue
- Nature Reviews Immunology
- Published
- 2023-04-17
- Volume
- 23
- Issue
- 10
- Pages
- 666-681
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC10108826
- OpenAlex
- W4366085911
- Semantic Scholar
- 5ffbde604bb1ef36987e5c29a105b9a8541a3137
- Cited by
- 524
- References
- 213
- Citations by year
- 2026: 146 · 2025: 184 · 2024: 151 · 2023: 43
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (LC170062)
- Deutsche Forschungsgemeinschaft (CRC877, SFB 877, CRC 841, 125440785)
- Deutsche Krebshilfe
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- interleukin-6, IL-6 trans-signalling, soluble IL-6 receptor, gp130, sgp130, IL-6 receptor alpha, inflammatory bowel disease, autoimmune disease, chronic inflammation, cancer, cytokine therapy
- MeSH terms
- Humans, Neoplasms, Interleukin-6, Cytokines, Receptors, Interleukin-6, Cytokine Receptor gp130
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
